RBC Capital Maintains Outperform on Encompass Health, Raises Price Target to $110
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Ben Hendrix has maintained an 'Outperform' rating on Encompass Health (NYSE:EHC) and raised the price target from $105 to $110.
October 30, 2024 | 3:45 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital has reaffirmed its 'Outperform' rating for Encompass Health and increased the price target to $110, indicating positive expectations for the stock.
The increase in price target from $105 to $110 by RBC Capital suggests a positive outlook for Encompass Health, likely leading to a short-term increase in stock price. The 'Outperform' rating indicates confidence in the company's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100